Two new studies released by Epicentre, the research arm of the international medical humanitarian organization Médecins Sans Frontières/ Doctors Without Borders (MSF) at the Conference on Retroviruses and Opportunistic Infections in Boston this week point to reductions in new HIV infections in areas where HIV treatment has been scaled up. Results also show viral suppression in one Malawian district twice as high as in the US.
8 hours ago | MSF
Two new medications to treat the deadly epidemic of hepatitis C promise millions of Americans a better chance of a cure, shorter periods of treatment and fewer side effects than older drugs. They also threaten to bust state budgets and raise private insurance rates.
04 March 2014 | USA Today
Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies. Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for equitable access to treatment for HCV, a curable infection that kills over 350,000 people each year.
28 February 2014 | Treatment Action Group
The Council of Europe expressed concern about the regressive legislative developments concerning access to health care for undocumented migrants in Spain on 29 January 2014.
21 February 2014 | PICUM
Battle lines are drawn as the global health community prepares to face off with Big Pharma over the astronomic cost of treatment.
19 February 2014 | HepMag
Police in the Deido section of Douala, Cameroon, arrested the vice president of the anti-AIDS pro-LGBT-rights group Alternatives-Cameroon on Feb. 14 after receiving an accusation that he is a homosexual.
The man who was arrested, Richard Kwa Bette, remained in detention today, awaiting word on what charges he would face.
Because of the arrest, Richard, a doctor, was unable to work on Feb. 15 at the association’s Health Center, where he was scheduled to oversee a health screening campaign for MSM (men who have sex with men) as part of Cameroon’s National Strategic Plan against HIV and Tuberculosis.
18 February 2014 | 76crimes.com
A recent survey of general practitioners by the Canadian Liver Foundation revealed 57 per cent of GPs don't know hepatitis C can be cured despite the fact more than 70 per cent of hep C patients who undergo treatment with available medicines are being cured right now.
14 February 2014 | Winnipeg Free Press
Gilead Sciences Inc. (GILD:US), the world’s largest maker of HIV medicines, said insurers have responded favorably over coverage of its new hepatitis C drug, which has a price tag of $84,000 for a 12-week course of treatment.
13 February 2014 | Bloomberg Businessweek
For all the leaks, changed stories, resignations, and embarrassment on the part of the pharmaceutical associations, the fate of South Africa’s patent policy remains undecided.
11 February 2014 | Science Speaks
Atripla is anticipated to be submitted to Russian health authority in May 2014. The price of Atripla in Estonia, Latvia and Lithuania will be reexamined and revised lower price will be offer to the appropriate authorities», - it is said in reply to open letter of EECA CAB.
11 February 2014 | EATG